Welcome to our dedicated page for The Carlyle Group SEC filings (Ticker: CG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Carlyle Group Inc. (NASDAQ: CG) files a range of documents with the U.S. Securities and Exchange Commission that provide detail on its operations, financing, and governance as a global investment firm. This page aggregates Carlyle’s SEC filings and pairs them with AI-powered summaries to help readers understand the key points in each report.
Recent Form 8-K filings show how Carlyle uses the capital markets and discloses material events. One 8-K describes the company’s quarterly financial results, furnished through a summary earnings press release and detailed earnings presentation. Other 8-Ks filed in September 2025 outline the pricing and issuance of $800 million aggregate principal amount of 5.050% Senior Notes due 2035, the related senior notes indenture, and the guarantees provided by several Carlyle holding entities. These filings explain the terms of the notes, including interest rate, maturity, redemption provisions, and events of default.
Another Form 8-K filed in July 2025 details leadership changes effective January 1, 2026, including the planned appointment of three Co-Presidents and a new Chief Financial Officer. The filing describes how these roles align with Carlyle’s Global Private Equity, Global Credit and Insurance, and Global Client Business segments, and notes that these senior professionals invest in and alongside Carlyle funds as described in the company’s proxy statement.
On this SEC filings page, users can review Carlyle’s 8-K current reports, as well as other core filings such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and registration statements when available. AI-generated highlights help explain complex sections, such as indenture covenants, guarantee structures, or executive compensation disclosures in proxy-related documents. The platform also surfaces real-time updates from EDGAR, allowing investors to see new filings as they are posted and to explore how Carlyle’s disclosures relate to its activities in private equity, credit, and investment solutions.
The Carlyle Group’s Chief Financial Officer Justin Plouffe reported equity compensation and related tax withholding in company stock. On February 1, 2026, 2,792 shares of common stock were withheld at $58.78 per share to cover taxes from vesting restricted stock units, and no shares were sold.
On the same date, Plouffe received 40,770 restricted stock units that vest 40% on August 1, 2027, 30% on August 1, 2028, and 30% on August 1, 2029, subject to continued service. He also received 9,704 restricted stock units vesting in three equal installments on February 1 of 2027, 2028, and 2029. After these transactions, he directly owned 949,893 shares of Carlyle common stock.
Carlyle Group Inc. Co-President Jeffrey Nedelman filed an initial ownership report showing beneficial ownership of 1,499,881 shares of common stock as of January 1, 2026. This total includes 1,322,750 restricted stock unit awards, which may convert into shares over time. The RSUs, including any accrued dividend equivalent units, vest only if certain time-based service requirements are met and, in some cases, if performance conditions tied to absolute stock price hurdles are achieved. All shares reported are held directly in his name.
Carlyle Group Inc. Co-President Mark David Jenkins filed an initial statement of beneficial ownership of securities. He reports holding 1,414,484 shares of Carlyle common stock in direct ownership. This total includes 1,109,310 restricted stock unit awards, which may convert into shares only if time-based service conditions and performance-based stock price hurdles are met. The filing does not report a new purchase or sale, but rather discloses Jenkins’ existing equity position as he serves as Co-President.
Carlyle Group Inc. Chief Financial Officer Justin Plouffe filed an initial ownership report showing beneficial ownership of 902,211 shares of Carlyle common stock as of 01/01/2026, all held directly. This total includes 755,057 restricted stock unit awards, along with related dividend equivalent units, that will vest only if specified time-based service requirements and performance-based stock price hurdles are met.
The Carlyle Group Inc. reports its beneficial ownership in Medline Inc. (MDLN) as a director and more than 10% owner. Through affiliated investment vehicles, it indirectly holds 158,245,640 shares of Medline Class A common stock and 77,742,972 shares of Class B common stock.
The filing explains that each share of Medline Class B common stock has one vote but no economic value, and is paired with one common unit of Medline Holdings, LP. Under a December 16, 2025 exchange agreement, holders may exchange these 77,742,972 common units for an equal number of Medline Class A shares on a one-for-one basis, with exchange rights that do not expire. When units are exchanged, the same number of Class B shares are automatically cancelled.
Carlyle Group Inc. reported an insider transaction by its Chief Executive Officer and director, Harvey M. Schwartz, related to equity compensation. On 12/15/2025, 310,696 shares of common stock were withheld by the company at a price of $58.35 per share to cover taxes due on the vesting of a previously reported restricted stock unit award. The filing states that no shares of common stock were sold by the reporting person in this transaction. Following the tax withholding, Schwartz beneficially owns 5,929,596 shares of Carlyle common stock in direct ownership.
Carlyle Group Inc. director David M. Rubenstein reported major share movements dated December 10, 2025. He made a charitable gift of 625,000 shares of Carlyle common stock, reported at a price of $0, and separately sold another 625,000 shares at $56.55 per share.
After these transactions, Rubenstein directly beneficially owned 27,999,644 shares of Carlyle common stock. The activity is reported on a Form 4 for one reporting person in his role as a director of Carlyle Group Inc.
Carlyle Group Inc. director reports charitable stock gifts. Director Anthony S. Welters filed a Form 4 showing two charitable donations of Carlyle common stock on 11/25/2025. One transaction transferred 11,706 shares at a reported price of $0, and a second transaction transferred 1,200 shares at a reported price of $0, each coded as a gift. After these transactions, Welters directly beneficially owned 43,399 shares of Carlyle common stock.
Carlyle Group Inc. (CG) reported an insider equity transaction involving its Chief Executive Officer and director, Harvey M. Schwartz. On 11/19/2025, Schwartz acquired 28,519 shares of common stock at a price of $0, bringing his total beneficial ownership to 6,240,292 shares held directly.
The new shares represent dividend equivalent units that accrued on existing time-based and performance-based restricted stock unit awards originally granted on February 15, 2023, in connection with Carlyle’s quarterly dividend. These dividend equivalent units will vest on the same schedule and under the same terms and conditions as the underlying restricted stock unit awards.
Carlyle Group Inc. (CG) filed a Form 4 reporting a routine equity award to its Chief Financial Officer. On 11/19/2025, the CFO acquired 3,730 shares of common stock at a price of $0. These shares are dividend equivalent units accrued on previously granted time-vesting restricted stock unit awards in connection with Carlyle’s quarterly dividend and will vest on the same schedule and terms as the underlying awards.
Following this transaction, the CFO beneficially owns 1,100,116 shares of Carlyle Group Inc. common stock in direct ownership form. The filing does not report any sales or derivative security activity, only the incremental dividend-related units tied to existing equity awards.